Skip to main contentAll experts

Tianze Jiao

AST PROF

PH-PHARM OUTCOMES & POLICY

Orcid identifier0000-0002-2608-616X (opens in a new tab)⁠
  • AST PROF
    PH-PHARM OUTCOMES & POLICY

GRANTS

  • GRANT
    Navigating the Uncertainties of Thyroid Cancer Risk in GLP-1RA Users
    National Institute of Health Nci24 Mar 2026 - 28 Feb 2031
    Active
  • GRANT
    The Impact of Idiopathic Hypersomnia on Cardiovascular, Cardiometabolic, and Renal Disorder Outcomes
    Sleep Research Society Foundation22 Dec 2025 - 21 Dec 2026
    Active
  • GRANT
    From Evidence to Policy: Tailoring GLP-1RA Coverage for Optimal Health Outcomes
    National Institute of Health Niddk20 Nov 2025 - 30 Jun 2026
    Expired
  • GRANT
    Patterns and outcomes of antiplatelets use in addition to anticoagulants in atrial fibrillation patients undergoing PCI
    American Heart Association23 Jan 2024 - 9 Jan 2025
    Expired
  • GRANT
    Assessing Barriers and Facilitators for Participating Structured Lifestyle Intervention
    Centers for Disease Control and Prevention6 Jun 2023 - 31 Aug 2026
    Active
  • GRANT
    Characterizing efficacy and safety of hormonal contraceptives by combining pharmacometrics and RWE
    Bill & Melinda Gates Foundation14 Nov 2022 - 31 Oct 2026
    Active
  • GRANT
    A personalized dynamic blood pressure control plan for cardiovascular disease prevention among patients with hypertension at low cardiovascular disease risk.
    Canadian Institutes of Health Research1 Apr 2020 - 31 Mar 2022
    People funded by this grant:
    • Filion KB,
    • Douros A,
    • Jiao T,
    • Platt RW
  • GRANT
    A personalized dynamic blood pressure control plan for cardiovascular disease prevention among patients with hypertension at low cardiovascular disease risk. (opens in a new tab)⁠
    Canadian Institutes of Health Research1 Apr 2020 - 31 Mar 2022
    People funded by this grant:
    • Platt RW,
    • Jiao T,
    • Filion KB,
    • Douros A
    MORELEARN MORE (opens in a new tab)